With the mission of addressing patients’ unmet medical needs through innovative theranostics, we are keen to explore various collaboration opportunities in discovery, development, manufacturing and commercialization with partners, such as research institutes of medical isotopes and radiopharmaceuticals, clinical centers, radiopharmaceutical companies, and biopharmaceutical companies from both China and abroad. We are thrilled to build our portfolio through diverse collaboration models including drug translation, co-development, in-licensing, and strategic partnership with leading players. We are continuously integrating resources and enhancing our capabilities to ensure the success of our partnerships.

As a company as well as open platform, we look forward to collaborating with our partners and improve the accessibility and affordability of precision diagnostic & therapeutic radiopharmaceutical solutions for patients in need.

Collaboration Models and Business Development